336 related articles for article (PubMed ID: 2661226)
1. Structure-function relationships of elongation factor Tu. Isolation and activity of the guanine-nucleotide-binding domain.
Jensen M; Cool RH; Mortensen KK; Clark BF; Parmeggiani A
Eur J Biochem; 1989 Jun; 182(2):247-55. PubMed ID: 2661226
[TBL] [Abstract][Full Text] [Related]
2. Functional role of the noncatalytic domains of elongation factor Tu in the interactions with ligands.
Cetin R; Anborgh PH; Cool RH; Parmeggiani A
Biochemistry; 1998 Jan; 37(2):486-95. PubMed ID: 9425069
[TBL] [Abstract][Full Text] [Related]
3. Properties of isolated domains of the elongation factor Tu from Thermus thermophilus HB8.
Nock S; Grillenbeck N; Ahmadian MR; Ribeiro S; Kreutzer R; Sprinzl M
Eur J Biochem; 1995 Nov; 234(1):132-9. PubMed ID: 8529632
[TBL] [Abstract][Full Text] [Related]
4. Properties of a genetically engineered G domain of elongation factor Tu.
Parmeggiani A; Swart GW; Mortensen KK; Jensen M; Clark BF; Dente L; Cortese R
Proc Natl Acad Sci U S A; 1987 May; 84(10):3141-5. PubMed ID: 3554231
[TBL] [Abstract][Full Text] [Related]
5. Effects of nucleotide- and aurodox-induced changes in elongation factor Tu conformation upon its interactions with aminoacyl transfer RNA. A fluorescence study.
Dell VA; Miller DL; Johnson AE
Biochemistry; 1990 Feb; 29(7):1757-63. PubMed ID: 2110000
[TBL] [Abstract][Full Text] [Related]
6. Substitution of Val20 by Gly in elongation factor Tu. Effects on the interaction with elongation factors Ts, aminoacyl-tRNA and ribosomes.
Jacquet E; Parmeggiani A
Eur J Biochem; 1989 Nov; 185(2):341-6. PubMed ID: 2684669
[TBL] [Abstract][Full Text] [Related]
7. Effects of the mutation glycine-222----aspartic acid on the functions of elongation factor Tu.
Swart GW; Parmeggiani A; Kraal B; Bosch L
Biochemistry; 1987 Apr; 26(7):2047-54. PubMed ID: 3297141
[TBL] [Abstract][Full Text] [Related]
8. Effects of the antibiotic pulvomycin on the elongation factor Tu-dependent reactions. Comparison with other antibiotics.
Anborgh PH; Okamura S; Parmeggiani A
Biochemistry; 2004 Dec; 43(49):15550-6. PubMed ID: 15581367
[TBL] [Abstract][Full Text] [Related]
9. Probing the reactivity of the GTP- and GDP-bound conformations of elongation factor Tu in complex with the antibiotic GE2270 A.
Anborgh PH; Parmeggiani A
J Biol Chem; 1993 Nov; 268(33):24622-8. PubMed ID: 8227020
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the elongation factors from calf brain. 3. Properties of the GTPase activity of EF-1 alpha and mode of action of kirromycin.
Crechet JB; Parmeggiani A
Eur J Biochem; 1986 Dec; 161(3):655-60. PubMed ID: 3024979
[TBL] [Abstract][Full Text] [Related]
11. Studies on polypeptide-chain-elongation factors from an extreme thermophile, Thermus thermophilus HB8. 2. Catalytic properties.
Arai K; Arai N; Nakamura S; Oshima T; Kaziro Y
Eur J Biochem; 1978 Dec; 92(2):521-31. PubMed ID: 367783
[TBL] [Abstract][Full Text] [Related]
12. Effects of mutagenesis of Gln97 in the switch II region of Escherichia coli elongation factor Tu on its interaction with guanine nucleotides, elongation factor Ts, and aminoacyl-tRNA.
Navratil T; Spremulli LL
Biochemistry; 2003 Nov; 42(46):13587-95. PubMed ID: 14622005
[TBL] [Abstract][Full Text] [Related]
13. Site-directed mutagenesis of elongation factor Tu. The functional and structural role of residue Cys81.
Anborgh PH; Parmeggiani A; Jonák J
Eur J Biochem; 1992 Sep; 208(2):251-7. PubMed ID: 1521523
[TBL] [Abstract][Full Text] [Related]
14. Effects of ions on the intrinsic activities of c-H-ras protein p21. A comparison with elongation factor Tu.
Mistou MY; Cool RH; Parmeggiani A
Eur J Biochem; 1992 Feb; 204(1):179-85. PubMed ID: 1740128
[TBL] [Abstract][Full Text] [Related]
15. Structure-function relationships in the GTP binding domain of EF-Tu: mutation of Val20, the residue homologous to position 12 in p21.
Jacquet E; Parmeggiani A
EMBO J; 1988 Sep; 7(9):2861-7. PubMed ID: 3181143
[TBL] [Abstract][Full Text] [Related]
16. Aminoacyl-tRNA-elongation factor Tu-ribosome interaction leading to hydrolysis of guanosine 5'-triphosphate.
Takahashi K; Ghag S; Chládek S
Biochemistry; 1986 Dec; 25(25):8330-6. PubMed ID: 3545292
[TBL] [Abstract][Full Text] [Related]
17. A chimeric elongation factor containing the putative guanine nucleotide binding domain of archaeal EF-1 alpha and the M and C domains of eubacterial EF-Tu.
Arcari P; Masullo M; Arcucci A; Ianniciello G; de Paola B; Bocchini V
Biochemistry; 1999 Sep; 38(38):12288-95. PubMed ID: 10493796
[TBL] [Abstract][Full Text] [Related]
18. Kirromycin drastically reduces the affinity of Escherichia coli elongation factor Tu for aminoacyl-tRNA.
Abrahams JP; van Raaij MJ; Ott G; Kraal B; Bosch L
Biochemistry; 1991 Jul; 30(27):6705-10. PubMed ID: 2065055
[TBL] [Abstract][Full Text] [Related]
19. The G222D mutation in elongation factor Tu inhibits the codon-induced conformational changes leading to GTPase activation on the ribosome.
Vorstenbosch E; Pape T; Rodnina MV; Kraal B; Wintermeyer W
EMBO J; 1996 Dec; 15(23):6766-74. PubMed ID: 8978702
[TBL] [Abstract][Full Text] [Related]
20. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
Wolf H; Chinali G; Parmeggiani A
Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4910-4. PubMed ID: 4373734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
